Medtronic plc. Ordinary Shares (MDT): Price and Financial Metrics


Medtronic plc. Ordinary Shares (MDT)

Today's Latest Price: $103.06 USD

0.37 (0.36%)

Updated Sep 30 3:22pm

Add MDT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 140 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

MDT Stock Summary

  • MDT has a higher market value than 98.77% of US stocks; more precisely, its current market capitalization is $138,037,465,152.
  • Medtronic plc's stock had its IPO on January 1, 1986, making it an older stock than 92.91% of US equities in our set.
  • In terms of volatility of its share price, MDT is more volatile than only 8.95% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Medtronic plc, a group of peers worth examining would be DHR, TMUS, SNY, UNP, and CHTR.
  • MDT's SEC filings can be seen here. And to visit Medtronic plc's official web site, go to www.medtronic.com.
MDT Daily Price Range
MDT 52-Week Price Range

MDT Stock Price Chart Technical Analysis Charts


MDT Price/Volume Stats

Current price $103.06 52-week high $122.15
Prev. close $102.69 52-week low $72.13
Day low $102.50 Volume 3,647,131
Day high $104.87 Avg. volume 5,921,638
50-day MA $102.26 Dividend yield 2.26%
200-day MA $101.57 Market Cap 138.53B

Medtronic plc. Ordinary Shares (MDT) Company Bio


Medtronic plc manufactures and sells device-based medical therapies worldwide. The company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The company was founded in 1949 and is based in Dublin, Ireland.

MDT Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$103.06$37.8 -63%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Medtronic plc. To summarize, we found that Medtronic plc ranked in the 23th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for MDT, they are:

  • Medtronic plc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than just 24.65% of tickers in our DCF set.
  • MDT's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than just 24.65% of tickers in our DCF set.
  • As a business, Medtronic plc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than merely 0% of stocks generating free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-64%
1%-64%
2%-63%
3%-63%
4%-62%
5%-62%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MDT, try SNN, BAX, GMED, HOLX, and OFIX.


MDT Latest News Stream


Event/Time News Detail
Loading, please wait...

MDT Latest Social Stream


Loading social stream, please wait...

View Full MDT Social Stream

Latest MDT News From Around the Web

Below are the latest news stories about Medtronic plc that investors may wish to consider to help them evaluate MDT as an investment opportunity.

Medtronic announces closing of €6.25B senior notes and redemption of outstanding notes

Medtronic (MDT) wholly-owned subsidiary Medtronic Global Holdings has closed senior notes offering of €6.25B.All of Medtronic Luxco's obligations under the notes are fully and unconditionally guaranteed by the Company and Medtronic, a wholly-owned indirect subsidiary of Medtronic Luxco, on a senior unsecured basis. Net proceeds of ~€6.2B will be used...

Seeking Alpha | September 29, 2020

Medtronic product removed from market in Australia, which is now investigating its use

Medtronic denies any wrongdoing in its marketing or sales of Infuse.

Star Tribune | September 29, 2020

Surgical Robots Market 2020 Segments Analysis: Intuitive Surgical, Accuray Incorporated, Stryker, MEDTRONIC, Smith & Nephew

"Surgical Robots Market" By Product Type (Instruments, Robotic Systems, Accessories and Services), Brands (DA Vinci Surgical System, CyberKnife, Renaissance, Artas, ROSA, Others), Application (General Surgery, Urological, Gynaecological, Gastrointestinal, Radical Prostatectomy, Cardiothoracic Surgery, Colorectal Surgery, Radiotherapy, Others), Geography (Europe, North America,

OpenPR | September 29, 2020

Intraoperative MRI Market 2020 is forecast to reach USD 75.0 Million by 2025 | GE, Siemens, Phillips, Medtronic and Hitachi

The growing demand for Intraoperative MRI has provided a major boost to the Global Intraoperative MRI Market as more people are shifting their preferences to this growing sector. The market is expected to keep rising at a high CAGR and

OpenPR | September 29, 2020

Outstanding Scope of Meniscus Repair Systems Market is Estimated to Grow Incredible CAGR till 2025 | J&J, Stryker, Arthrex, Zimmer Biomet, Medtronic, Smith & Nephew, Arcuro Medical

Global Meniscus Repair Systems Market Synopsis: The report covers a forecast and an analysis of the Meniscus Repair Systems Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast

OpenPR | September 29, 2020

Read More 'MDT' Stories Here

MDT Price Returns

1-mo -3.56%
3-mo 11.25%
6-mo 20.93%
1-year -2.53%
3-year 41.72%
5-year 61.65%
YTD -7.47%
2019 27.34%
2018 15.18%
2017 15.90%
2016 -5.44%
2015 8.62%

MDT Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MDT Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.0336 seconds.